Gene therapy 'incubator' to be built by 2029 in Lake Success Biogenesis Park, officials say
The incubator is designed to draw cell and gene therapy researchers and drugmakers to work at the hub, where they can develop ...
$430 million cell and gene therapy center is coming to Long Island. Here's more on New York Biogenesis Park.
Gov. Kathy Hochul on Tuesday announced a $150 million investment in a new state-of-the-art cell and gene therapy hub to be ...
Hosted on MSN22h
MIND Diet and Cognitive Decline; Gene Therapy for Parkinson's; Curbing MS Fatigue
The MIND diet was associated with slower cognitive decline in both Black and white older adults, but relationships appeared ...
FierceBiotech11h
Ocuphire Pharma to transform into gene-therapy-focused biotech via Opus acquisition
Eye drug maker Ocuphire Pharma is acquiring gene therapy developer Opus Genetics in an all-stock transaction that will see ...
BioSpace6h
Sangamo’s Fabry Gene Therapy Could Hit Market 3 Years Earlier With FDA Accelerated Approval Pathway
The regulator agreed to allow Sangamo Therapeutics to use data to seek accelerated approval for its Fabry gene therapy ...
Pharmaceutical Technology6h
Ocuphire and Opus Genetics merge to develop IRD gene therapy
Ocuphire Pharma has announced the acquisition of Opus Genetics to develop gene therapies for inherited retinal diseases (IRDs ...
Long Island Business News20h
$430M cell and gene therapy hub planned for Long Island
Visiting Nassau County on Tuesday, Gov. Kathy Hochul announced plans for the New York BioGenesis Park, a $430 million, ...
FiercePharma5h
Roche's Vabysmo will rise above Eylea biosim threat, exec says, as DMD gene therapy Elevidys delivers sales surprise
By squeezing Regeneron’s Eylea, eye disease drug Vabysmo has become one of the biggest growth drivers for Roche. | Despite ...
Seeking Alpha1h
Sangamo: Fabry Disease Gene Therapy Moves Forward With Positive FDA Regulatory Development
The significance of this is that it brings about the ability to obtain FDA approval for this AAV gene therapy without the need to run a phase 3 study. Even better, it has another positive worth ...
Science Daily1h
Researchers flip genes on and off with AI-designed DNA switches
Researchers have used artificial intelligence to design thousands of new DNA switches that can precisely control the expression of a gene in different cell types. Their new approach opens the ...
More Pfizer layoffs hit North Carolina
Months after disclosing significant layoffs across its North Carolina operations, Pfizer (NYSE: PFE) plans to eliminate more ...
The Guardian Nigeria23h
1st sickle cell gene therapy patient completes treatment
A 12-year-old boy has become the first patient in the U.S. to receive gene therapy for sickle cell disease, The New York Times reported Oct ...